149 related articles for article (PubMed ID: 37129237)
1. MicroRNA dysregulation and therapeutic opportunities in esophageal diseases.
Markey GE; Donohoe CL; McNamee EN; Masterson JC
Am J Physiol Gastrointest Liver Physiol; 2023 Jul; 325(1):G1-G13. PubMed ID: 37129237
[TBL] [Abstract][Full Text] [Related]
2. Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus.
Craig MP; Rajakaruna S; Paliy O; Sajjad M; Madhavan S; Reddy N; Zhang J; Bottomley M; Agrawal S; Kadakia MP
Clin Transl Gastroenterol; 2020 Jan; 11(1):e00125. PubMed ID: 31934893
[TBL] [Abstract][Full Text] [Related]
3. Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.
Kauttu T; Mustonen H; Vainionpää S; Krogerus L; Ilonen I; Räsänen J; Salo J; Puolakkainen P
Clin Transl Oncol; 2017 Jan; 19(1):58-66. PubMed ID: 27026568
[TBL] [Abstract][Full Text] [Related]
4. A review of the current understanding and clinical utility of miRNAs in esophageal cancer.
Sakai NS; Samia-Aly E; Barbera M; Fitzgerald RC
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):512-21. PubMed ID: 24013023
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
Smith CM; Watson DI; Michael MZ; Hussey DJ
World J Gastroenterol; 2010 Feb; 16(5):531-7. PubMed ID: 20128019
[TBL] [Abstract][Full Text] [Related]
7. Pediatric eosinophilic esophagitis is associated with changes in esophageal microRNAs.
Zahm AM; Menard-Katcher C; Benitez AJ; Tsoucas DM; Le Guen CL; Hand NJ; Friedman JR
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G803-12. PubMed ID: 25147232
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.
Drahos J; Schwameis K; Orzolek LD; Hao H; Birner P; Taylor PR; Pfeiffer RM; Schoppmann SF; Cook MB
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):429-37. PubMed ID: 26604271
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
Wu X; Ajani JA; Gu J; Chang DW; Tan W; Hildebrandt MA; Huang M; Wang KK; Hawk E
Cancer Prev Res (Phila); 2013 Mar; 6(3):196-205. PubMed ID: 23466817
[TBL] [Abstract][Full Text] [Related]
10. [Esophageal diseases: GERD, Barrett, achalasia and eosinophilic esophagitis].
Calvet X; Villoria A
Gastroenterol Hepatol; 2014 Sep; 37 Suppl 3():53-61. PubMed ID: 25294266
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers.
Lu TX; Sherrill JD; Wen T; Plassard AJ; Besse JA; Abonia JP; Franciosi JP; Putnam PE; Eby M; Martin LJ; Aronow BJ; Rothenberg ME
J Allergy Clin Immunol; 2012 Apr; 129(4):1064-75.e9. PubMed ID: 22391115
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer.
Garman KS; Owzar K; Hauser ER; Westfall K; Anderson BR; Souza RF; Diehl AM; Provenzale D; Shaheen NJ
Dig Dis Sci; 2013 Nov; 58(11):3178-88. PubMed ID: 23925817
[TBL] [Abstract][Full Text] [Related]
14. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets.
Lu S; Mukkada VA; Mangray S; Cleveland K; Shillingford N; Schorl C; Brodsky AS; Resnick MB
PLoS One; 2012; 7(7):e40676. PubMed ID: 22815788
[TBL] [Abstract][Full Text] [Related]
16. Circulating exosomal miRNAs as potential biomarkers for Barrett's esophagus and esophageal adenocarcinoma.
Lv J; Zhao HP; Dai K; Cheng Y; Zhang J; Guo L
World J Gastroenterol; 2020 Jun; 26(22):2889-2901. PubMed ID: 32587437
[TBL] [Abstract][Full Text] [Related]
17. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
19. [Esophageal diseases: gastroesophageal reflux disease, Barrett's esophagus and eosinophilic esophagitis].
Calvet X
Gastroenterol Hepatol; 2011 Oct; 34 Suppl 2():27-35. PubMed ID: 22330154
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.
Yang H; Gu J; Wang KK; Zhang W; Xing J; Chen Z; Ajani JA; Wu X
Clin Cancer Res; 2009 Sep; 15(18):5744-52. PubMed ID: 19737949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]